ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puchelle, E
Right arrow Articles by Polu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puchelle, E
Right arrow Articles by Polu, J.
Eur Respir J 1996; 9: 765-769
Copyright © ERS Journals Ltd 1996

Original Articles

Effects of rhDNase on purulent airway secretions in chronic bronchitis

E Puchelle, JM Zahm, S de Bentzmann, C Grosskopf, S Shak, D Mougel, and JM Polu

Recombinant human deoxyribonuclease (rhDNase) has been demonstrated to reduce in vitro the viscosity and to improve the transport capacity of purulent respiratory mucus in cystic fibrosis. During episodes of exacerbation of chronic bronchitis, the patients generally expectorate purulent mucus. Purulence of mucus is associated with an increased deoxyriboneucleic acid (DNA) concentration. We analyzed in vitro the potential effect of rhDNase on chronic bronchitis mucus transport by the ciliary activity (frog palate model) and by simulated cough (cough machine model), as well as the effect on mucus viscosity (controlled stress rheometer) and surface properties (contact angle). Purulent sputa collected from patients with chronic bronchitis (n = 15) during an episode of exacerbation were incubated for 30 min at 37 degrees C with either rhDNase at two different concentrations (final concentration 2 or 4 micrograms.mL-1) or placebo. The median mucociliary transport rate was significantly improved by rhDNase from 0.68 with placebo to 0.79 and 0.83 with 2 and 4 micrograms.mL-1 of rhDNase, respectively. A significant improvement in mucus cough transport was also induced by rhDNase from 25.5 mm with placebo to 27.0 mm with either 2 or 4 micrograms.mL-1 rhDNase. These improvements in mucus transport capacity were associated with alterations in the physical properties of the mucus. The mucus median control viscosity (511.4 Pa.s) and median contact angle (0.85 rd) significantly decreased to 112.5 Pa.s and 0.74 rd, respectively, in the presence of 4 micrograms.mL-1 of rhDNase. These findings demonstrate that recombinant deoxyribonuclease may exert a beneficial effect on mucus clearance in vitro by altering the viscosity and surface properties of the purulent chronic bronchitic sputum samples.


This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
S S Manna, J Shaw, S M Tibby, and A Durward
Treatment of plastic bronchitis in acute chest syndrome of sickle cell disease with intratracheal rhDNase
Arch. Dis. Child., July 1, 2003; 88(7): 626 - 627.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. N. SANDERS, S. C. DE SMEDT, E. VAN ROMPAEY, P. SIMOENS, F. DE BAETS, and J. DEMEESTER
Cystic Fibrosis Sputum . A Barrier to the Transport of Nanospheres
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1905 - 1911.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
P. M. QUINTON
Physiological Basis of Cystic Fibrosis: A Historical Perspective
Physiol Rev, January 1, 1999; 79(1): 3 - 22.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.